	Transcriptomic and experimental evidence confirm the potential of disulfidptosis-related signature for the early diagnosis and treatment of liver cirrhosis. PLoS One Liu Y, Zhang R, Sun X, Cui W, Liu L. PMID: 41223189 [PubMed - in process]
	Future Management of Sepsis in Liver Cirrhosis. J Clin Exp Hepatol Jain A, Singh S, Maiwall R. PMID: 41216590 [PubMed]
	Assessing the Accuracy of Contrast-Enhanced CT Abdomen in Identifying and Stratifying Risk of Oesophageal Varices in Cirrhotic Patients: A Retrospective Study. Cureus Collins HJ, Chitturi S, Sharma S, Jain T. PMID: 41216058 [PubMed]
	Liver Maximum Capacity (LiMAx) Test Is a Promising Tool to Predict Fibrosis and Cirrhosis in Chronic Liver Disease: A Systematic Review. Cureus Joshi A, Patel E. PMID: 41216046 [PubMed]
	Tolvaptan versus other interventions for hyponatraemia in people with cirrhosis. Cochrane Database Syst Rev Anila KN, Saraswathy NS, Mohamed ZU, Varghese CT, Binoj ST, Gopalakrishnan U, Balakrishnan D, Valsan A, Sudhindran S. PMID: 41211728 [PubMed - indexed for MEDLINE]
	Author Response: Pitfalls in the Diagnosis of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Indian J Crit Care Med Yadav S, Ekka M, Vinayak MS. PMID: 41210539 [PubMed]
	Pitfalls in the Diagnosis of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Indian J Crit Care Med Kumar M, Sundarsingh V. PMID: 41210537 [PubMed]
	Application of methylene blue injection staining in the diagnosis of hepatic pleural effusion in patients with cirrhosis-a case report and literature review. AME Case Rep Xing Z, Wang H. PMID: 41210445 [PubMed]
	Right Ventricular Contractility Predicts Clearance of Ascites After Transjugular Intrahepatic Portosystemic Shunt. Liver Int Heger LA, Chang J, Rohrer C, Reincke M, Eyth A, Sturm L, Schultheiss M, Maier A, Meyer C, Jansen C, Graf K, Öztürk C, Schneider F, Trebicka J, Westermann D, Thimme R, Grundmann S, Praktiknjo M, Bettinger D. PMID: 41204773 [PubMed - indexed for MEDLINE]
	The role of hypothyroidism in cirrhosis pathogenesis: A retrospective cohort study and multi-omics integration analysis. PLoS Genet Yang Z, Liang W, Zhang Q, Weng C, Deng H, Wen Z, Wu J, Deng J, Xie Z, Lin Y, Fu X, Gu C, Yang T, Yang H, Zhou J. PMID: 41202080 [PubMed - in process]
	Aspartate aminotransferaseâ€‘toâ€‘platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitis. Ann Hepatol Baven-Pronk MAMC, Marijnissen CJM, Biewenga M, Stättermayer AF, Tushuizen ME, van Hoek B. PMID: 41201610 [PubMed - as supplied by publisher]
	Serum IL-17F as a biomarker of infection-independent cirrhosis progression. Front Immunol Konstantis G, Passenberg M, Guntlisbergen C, Schütte A, Jung B, Nuruzade N, Seltsam F, Hoyer DP, Best J, Willuweit K, Schmidt HH, Guckenbiehl S, Rashidi-Alavijeh J. PMID: 41200179 [PubMed - indexed for MEDLINE]
	Insights Into NASH-Related Cirrhosis: Clinical and Histopathological Perspectives From Liver Transplant Specimens. APMIS Soleimani N, Jalalian Z, Anbardar MH, Mokhtari M, Mohammadzadeh S, Kazemi K, Malek-Hosseini SA, Nikoupour H, Soleimani D, Mohajerani S, Dehghani S. PMID: 41199685 [PubMed - indexed for MEDLINE]
	Endoscopic ultrasound versus conventional endoscopic cyanoacrylate glue injection for the management of gastrointestinal bleeding in cirrhosis: a randomized controlled trial. Surg Endosc Bai Y, Wang Z, Kuai Y, Mei X, Kong J, Kong D. PMID: 41198927 [PubMed - as supplied by publisher]
	Human Albumin infusion in liver Cirrhosis and overt Hepatic Encephalopathy (HACHE): protocol of an investigator-initiated, open-label, multicentre, randomised controlled trial. BMJ Open Li Q, Tong H, Liu X, Liao F, Ma H, Zhou Z, Liu F, Shi H, Wang Z, Sun Y, Yao Q, Feng Y, Li X, Feng J, He Z, Peng Y, Bai Z, Zhu R, Cheng D, Xu C, He S, Yu H, Xie C, Yuan J, Wang X, Yang H, Zou Y, Li S, Li T, Hu S, Chen C, Chen Z, Lantinga MA, Bernardi M, Qi X, Tang C, On the behalf of Young Member Group of Chinese Gastroenterology Society. PMID: 41198206 [PubMed - indexed for MEDLINE]
	Impact of liver cirrhosis on postoperative outcomes following total hip and knee arthroplasty : a systematic review and meta-analysis. Bone Jt Open Asgari AM, Shaker F, Malekshahi M, Tavakoli K, Behroo F, Pahlevan-Fallahy MT, Kasaeian A. PMID: 41197662 [PubMed]
	Machine learning-based nomogram for mortality risk stratification in cirrhotic patients with sepsis: a single-center predictive model. Front Med (Lausanne) Zhang XC, Li BW, Lei XQ, Shan NB, Wei JP, Lu ZH, Sun Y. PMID: 41195174 [PubMed]
	Prevalence of advanced fibrosis risk using FIB-4 in patients with type 2 diabetes and its associated factors: a cross-sectional study in a primary care unit of a university hospital in Southern Thailand. BMC Prim Care Ananchaisarp T, Chamroonkiadtikun P, Bunchote K, Thedpun J, Srisamoot C, Rujiworanat C, Jayasakul V, Chaiphom N, Kittivarapong T, Chuaysong N, Sripongpun P. PMID: 41193987 [PubMed - indexed for MEDLINE]
	Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial. Cell Discov He K, Zhu XJ, Shi YP, Huang WJ, Yang TH, Xi ZF, Li QG, Sun HY, Qian LJ, Chen XS, Li PY, Zhou X, Gu GY, Li F, Liu WM, Chen CY, Zhao J, Wu HP, Yan FR, Ott M, Sharma AD, Liu H, Yu WF, Zhai B, Yan HX, Xia Q. PMID: 41193418 [PubMed]
	Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes. BMJ Open Diabetes Res Care Lu L, Gao C, Wu N, He S, Liu Y, Zhang N, Zhou J. PMID: 41192932 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 37154

Page 1 of 1858



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy